Synektik S.A.

Agents specialised in the sale of other particular products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-02-04
Share capital
4,264,564.50 PLN
Activity description

Synektik offers complementary products and services for medical facilities. The Group delivers multidisciplinary projects tailored to the needs of these facilities.

Registered address
ul. Józefa Piusa Dziekońskiego 3, 00-728 Warszawa, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-63755-35647-AUWBR-26

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 65 days early. All were audited by a statutory auditor.

  • 202518/02/2026
  • 202431/01/2025
  • 202311/03/2024
  • 202221/03/2023
  • 202116/02/2022
  • 202024/02/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 321.40
-6.60 (-2.01%)
320.00325.00330.00321.4010:0012:0014:0016:00
Open
PLN 330.20
High
PLN 331.00
Low
PLN 316.60
Volume
16.8K
Avg. vol.
20.1K
Market cap
PLN 2.74B
P/E ratio
6.57
EPS
PLN 48.93
Shares outstanding
8.53M
52-week
PLN 310.20 – 339.40
Dividend yield
3.34%
Dividend
PLN 10.75
Ex dividend date
Jan 28, 2026
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 78.95mUSD 17.86mUSD 14.88m
Q1 2026USD 57.59mUSD 14.51mUSD 80.05m
Q4 2025USD 57.25mUSD 13.55mUSD 8.78m
Q3 2025USD 50.03mUSD 12.44mUSD 7.77m

Results for Q4 2025:Nov 18, 2026

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Wholesale trade272 / 20,037
Top 1.4%
City · Warszawa535 / 56,729
Top <1%
Voivodeship · Mazowieckie680 / 76,892
Top <1%
Country · Poland1,895 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 120.32mMedianUSD 226.53kAverageUSD 2.28m
Net profit
This companyUSD 23.09mMedianUSD 6.28kAverageUSD 141.81k
Operating costs
This companyUSD 85.70mMedianUSD 187.76kAverageUSD 2.07m
Assets
This companyUSD 86.82mMedianUSD 161.96kAverageUSD 1.33m

Websites

The site is available in: Polish, English and Ukrainian.

  • zbadani.plZbadani.pl | Dla pacjentów
    LinkedIn AdsGoogle AnalyticsGoogle Tag ManagerMeta PixelApache

Public procurement

377 tenders recorded as contractor: 135 national ($10,864,372) and 242 EU ($280,364,556).

SubjectAmount
Provision of post-warranty service for the da Vinci model X surgical system and repair programme for advanced and basic endoscopes at Samodzielny Publiczny Szpital Kliniczny im. Prof. w. Orłowskiego CMKP
$448.8K
Supply of tools and products for the contracting authority's da vinci X surgical robot, knee joint prostheses, endoprostheses (...), divided into 14 lots.
$646.8K
D-31/N/26 Supply of products for procedures using a robotic system (Urology Operating Theatre) for a period of 24 months
$490.4K

Trademarks

The company holds 3 active trademarks registered with the Polish Patent Office. The first mark was filed in 2014.

MarkNumberClassesStatusProtected until
zbadani.pl Z.5223559, 35, 38, 42, 44Protected Dec 17, 2030
ARPACS Z.4356595, 9, 10, 16, 35, 36, 37, 38, 41, 42, 45Protected Nov 13, 2034
Synektik Z.4356605, 9, 10, 16, 35, 36, 37, 38, 41, 42, 45Protected Nov 13, 2034
MarkProtected until
zbadani.pl Dec 17, 2030
ARPACS Nov 13, 2034
Synektik Nov 13, 2034

Authorized Representatives

Artur Mieczysław Ostrowski age 68 – Attorney-in-fact (joint)
Cezary Dariusz Kozanecki age 66 – President of the Management Board
Dariusz Marcin Korecki age 53 – Vice President of the Management Board
Tomasz Wróbel age 66 – Management Board Member

Manner of representation

If the management board is a multi-member management board, the President of the Management Board independently, or two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy, are authorized to submit declarations of will on behalf of the company.

Supervisory board

Andrzej Piotr Jacaszek age 66 – Supervisory Board Member
Michał Daniel Dobak age 63 – Supervisory Board Member
Mariusz Wojciech Książek age 54 – Supervisory Board Member
Wiesław Tadeusz Łatała age 60 – Supervisory Board Member
Sawa Zuzanna Zarębińska age 61 – Supervisory Board Member

Beneficial owners

Synektik is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.

Subsidiaries

NameStake
LOM Scan sp. z o.o.
48.9926%
Synektik Pharma sp. z o.o.
100%
It4kan sp. z o.o.
100%

Capital group

The company is the parent company of a corporate group.

NameCountry
Synektik Czech Republic, S.R.O.Czechia

Bank accounts

Registered as a VAT taxpayer on 2003-12-31.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jul 29, 2011Commercial Companies Code notice
Jul 11, 2011Commercial Companies Code notice
Mar 7, 2011Transformation registered

Public aid

14 public aid cases recorded, with a total value of $1,327,049.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$65,153
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$145.7K
Other crisis aid
$53,718

European Funds

5 projects recorded: 4 from FE lists ($2,414,370) and 1 Commission grant (FTS) ($4,079,437).

ProjectEU co-financing
Data lake in radiology – development of repositories for research purposes
$246.4K
Dosimetry and diagnostic imaging - effective radiation protection for patients
$193.2K
Evolution Platform as a response to the process of experimenting and searching for development and innovation niches at the intersection of selected smart specialisations
$505.1K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Bialmed sp. z o.o.
Pelion S.A.
Hammermed Medical Polska S.K.A.
Skamex S.A.
Baxter Polska sp. z o.o.
Anmar sp. z o.o.
Centrum Zaopatrzenia Medycznego Cezal - Wrocław S.A.
Informer Med sp. z o.o.
J.Chodacki, A.Misztal, Medica sp. j.
Versamed sp. z o.o.

Change history

DateEvent
2021-08-13Address change
2015-01-19PKD change
2014-07-15Address change
2014-01-03Share capital increase
2013-08-28Share capital increase

FAQ

Last updated: 2026-03-27